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ABSTRACT
There is an ongoing interest in studying the effect of common recurrent infections and conditions, such 
as diarrhoea, respiratory infections, and fever, on the nutritional status of children at risk of malnutrition. 
Epidemiological studies exploring this association need to measure infections with sufficient accuracy to 
minimize bias in the effect estimates. A versatile model of common recurrent infections was used for ex-
ploring how many repeated measurements of disease are required to maximize the power and logistical 
efficiency of studies investigating the effect of infectious diseases on malnutrition without compromising 
the validity of the estimates. Depending on the prevalence and distribution of disease within a population, 
15-30 repeat measurements per child over one year should be sufficient to provide unbiased estimates of 
the association between infections and nutritional status. Less-frequent measurements lead to a bias in 
the effect size towards zero, especially if disease is rare. In contrast, recall error can lead to exaggerated ef-
fect sizes. Recall periods of three days or shorter may be preferable compared to longer recall periods. The 
results showed that accurate estimation of the association between recurrent infections and nutritional 
status required closer follow-up of study participants than studies using recurrent infections as an outcome 
measure. The findings of the study provide guidance for choosing an appropriate sampling strategy to 
explore this association.
Key words: Diarrhoea; Epidemiology; Infections; Measurement; Nutritional status
INTRODUCTION
Nutritional status is an important risk factor for 
many infectious diseases in childhood (1-3) and 
for impairments in cognitive development and 
premature death (1). The effect of common recur-
rent infections and conditions, such as diarrhoea, 
respiratory infections, and fever, on gain in weight 
and growth of children is subject to an ongoing de-
bate (4-6). To set the right public-health priorities 
to achieve sustained improvements in health and 
economic development in low-income settings, it 
is important to obtain a better understanding of 
the link between infectious diseases and nutrition 
(5). 
Epidemiological studies exploring the effect of in-
fections on nutritional status encounter a number 
of methodological challenges. In addition to con-
founding, another challenge is the choice of the 
surveillance strategy to measure the prevalence of 
infections which, in contrast to assessing the nu-
tritional status of children, usually requires many 
repeated measurements. In an individual child, the 
presence or absence of infection is much more vari-
able over time than, for example, the child’s weight 
or height. It is not clear how precise the measure-
ment of the prevalence of the infectious disease un-
der study needs to be to estimate reliably the associa- 
tion between recurrent infections and nutritional 
status. The objective of this study was to identify 
the optimal balance between two contrasting barri-
ers to obtaining valid estimates: 
(a) If the measurement of the individual child’s risk 
of infection is too imprecise (i.e. based on too few 
repeated measurements), the resulting estimate of 
the association between infection and nutrition 
will not only be imprecise but will also be biased 
towards null (7).
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(b) If many repeat measurements are conducted, 
the information to be gained from further repeated 
measurements diminishes rapidly with the increas-
ing number of measurements, i.e. after a certain 
number of measurements, the burden of disease 
of an individual child would be determined with 
sufficient accuracy and can hardly be improved by 
further visits (8). Also, many repeated household 
surveys require a large number of field workers who 
need to be recruited, trained, and supervised, often 
at high costs. Frequent visits to households partici-
pating in the study may compromise their willing-
ness to be recruited, or to cooperate once the study 
is underway (8). There is evidence that reporting of 
disease by household members, usually the carer of 
the child, diminishes over time and at times causes 
a decline in measured disease prevalence which 
cannot be explained by changes in the age distri-
bution and seasonal trends alone (9). Frequent vis-
its may also change the healthcare-seeking and risk 
behaviour of households, thus influencing the out-
come of interest (10). Parents may become more 
alert to symptoms and seek more medical care, or 
field workers may try to correct bad practices for 
professional and ethical reasons. For these different 
reasons, it is preferable to limit the number of re-
peated surveys to what is absolutely necessary. 
Using a versatile model of common recurrent infec-
tions (11), we explored how many repeated meas-
urements of disease are required to maximize the 
power and logistical efficiency of studies inves-
tigating the effect of infectious diseases on malnu-
trition without compromising the validity of the 
estimates. 
MATERIALS AND METHODS
Description of model
The model is probabilistic. Its details are described 
elsewhere (11). The model has been used for evalu-
ating the appropriateness of sampling strategies of 
common recurrent infections (8). In this study, it 
was used for investigating the sampling strategies 
required for exploring the effect of infectious dis-
eases on malnutrition. 
The basic model is summarized briefly as follows: 
The model simulates the daily variation of recurrent 
infections in individuals in a hypothetical popula-
tion over one year. It is characterized by three com-
ponents: incidence of episode, duration of episode, 
and a linear association between the incidence and 
the mean duration of episode, since individuals 
with more episodes tend to suffer from longer epi-
sodes (11). The incidence of episode and the dura-
tion of episode are modelled separately by Gamma 
distributions. Gamma distributions are useful to 
model highly skewed data, such as an individual’s 
number of episodes of disease over a specified time 
period, where most individuals experience few epi-
sodes while a small number of high-risk individuals 
experience many episodes (11). All model param-
eters (i.e. those characterizing the probability dis-
tributions of incidence of episode and duration of 
episode and the positive correlation between inci-
dence and duration) are estimated by least squares 
fitting of the model to observations of data from 
different field trials.    
To circumvent the need for performing many simu- 
lations, four model scenarios were generated using 
permutations of parameter values to represent re-
alistic and contrasting epidemiological scenarios 
observed in the field. Specifically, the scenarios and 
the model parameters were derived from longitudi-
nal studies on diarrhoea, respiratory infections, and 
fever conducted in Brazil, Guatamala, Ghana, Thai-
land, Bangladesh, and other countries (8,11). The 
scenarios can be conceptualized by a two-by-two 
matrix in which the rows correspond to disease-
incidence risk (low/high) and the columns corres- 
pond to duration of episode (short/long) Fig. 1 and 
Table 1). 
The four scenarios are: (a) low incidence of disease 
and short duration of episode (LS), (b) low inci-
dence of disease and long duration of episode (LL), 
(c) high incidence of disease and short duration of 
episode (HS), and high incidence of disease and 
long duration of episode (HL). 
Simulation of nutritional status
The effect of recurrent infections on nutritional 
status was simulated as a linear association be-
tween the proportion of time ill during 365 days 
of follow-up and the gain in weight of a child dur-
ing that period. We used the proportion of time 
ill [subsequently termed ‘longitudinal prevalence’ 
(LP)] (12,13) as the exposure since this measure 
has been shown to be a better predictor of weight 
gain than the number of episodes (incidence) (12, 
14) and has, therefore, been used in many stud-
ies on the effect of infections on nutritional status 
(4,14-18). For simplicity, we only considered a one- 
way causal association between infection and wei- 
ght gain, ignoring that nutritional status can have 
an effect on the risk of infection (2). 
We used data from a large vitamin A trial in Ghana 
as parameters of weight gain over the simulated 
study period (19). Based on these data, we assumed 
that the difference in weight between the end and 
the beginning of the one-year observation period in 
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Fig. 1. Assumed gamma distributions for incidence and duration of episode, reproduced from (8) 
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children aged less than two years follows a normal 
distribution with a mean of 2 kg and a standard 
deviation of 0.8 kg. From the values of the weight 
gain for each child, we subtracted an amount that 
fully depended on the longitudinal prevalence of 
disease in that child over the simulated period of 
365 days. Thus, we assumed that the association 
between disease and weight gain can be expressed 
by the following equation:
      Weight gain (kg)=2.0-β*LP+ε                            [1]
where β is the regression coefficient of the linear 
association between disease and weight gain; LP is 
the longitudinal prevalence (=proportion of time 
ill) of an individual; and ε is the deviation of the 
simulated weight gain from the mean (i.e. epsilon 
is a normally-distributed variable of mean zero and 
standard deviation of 0.8). 
For the slope parameter β, we assumed that gain in 
weight decreases with every additional percentage 
point LP by 25 g, which corresponds approximate-
ly to published data based on field observations 
(12,14,18).
Importantly, the choice of the measure for nutri-
tional status (alternatives would have been, for 
example, gain in height, or weight/height-for-age 
z-scores) did not influence the model output (see 
Discussion). 
Simulated surveillance strategies
In addition to simulating the daily time course of 
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Table 1. Four model scenarios with examples as an outcome
Incidence Short duration of episode (α=0.8, 
β=2.7)
Long duration of episode (α=1.3, β=4.6)
Low incidence 
(α=0.6, β=2.1)
Model scenario 1 (LS) Model scenario 2 (LL)
Annual incidence: 0.9/person-year Annual incidence: 0.9/person-year
Mean duration of episode: 2.7 days Mean duration of episode: 5.6 days
Examples
-Diarrhoea or fever in low-risk 
child population  (20)
Examples
-ALRI in malnourished child populations 
(19,21)
-Diarrhoea in an area with very heteroge-
neous risk (22)
High incidence 
(α=1.2, β=6.8)
Model scenario 3 (HS) Model scenario 4 (HL)
Annual incidence: 7.0/person-year Annual incidence: 7.0/person-year
Mean duration of episode: 2.7 days Mean duration of episode: 5.6 days
Examples
-Diarrhoea or fever in high-risk
child populations (2,21)
Examples
-Diarrhoea in very poor settings in under-
nourished children (19)
-Mild ARI in high-risk population (19,21)
α and β values correspond to the parameters of the specified gamma distribution; reproduced from (8). 
ALRI=Acute lower respiratory infection; ARI=Acute respiratory infection; HL=High incidence of disease 
and long duration of episode; HS=High incidence of disease and short duration of episode; LL=Low 
incidence of disease and long duration of episode; LS=Low incidence of disease and short duration of 
episode
recurrent infections of a hypothetical population 
of individuals in the four contrasting scenarios des- 
cribed earlier, the model was also used for simulat-
ing surveillance visits at various intervals. At each 
visit, the model simulated the measurement of 
point prevalence by asking the hypothetical inter-
viewee or their carer the question “on which of the 
previous 7 days did you have the disease” and tak-
ing into account the probability of recall error by 
the interviewee. The types of recall error and their 
details are given elsewhere (8). To summarize, the 
model assumed that if the disease was present at 
two days before the visit, it is always reported (i.e. 
with 100% probability) whereas if the disease was 
present earlier than two days, the probability of it 
being reported decreases the longer the lag period 
(23) (Table 2). The model was also used for simu-
lating the measurment weekly period prevalence 
(i.e. “did you have the disease at any time during 
the last week”) which provides information on the 
number of weeks instead of days with the disease. 
This measure was used in many diarrhoea-inter-
vention studies (24,25), especially in demographic 
health surveys. 
Analysis
The longitudinal estimates of prevalence resulting 
from the different sampling strategies represent es-
timates of the ‘true’ proportion of time ill in a child, 
here defined as the proportion of time ill if all 365 
days had been recorded with 100% accuracy. Since 
the simulated association between disease and 
weight gain depends fully on the ‘true’ longitudi-
nal prevalence, we were able to explore how the 
‘true’ association is estimated if the longitudinal 
prevalence estimates are based on fewer measure-
ments, i.e. are less precise. We did this using linear 
regression, with the regression coefficient (i.e. the 
decrease in weight gain per additional percentage 
point of longitudinal prevalence) as the model out-
put. We assumed a decreasing number of visits dur-
ing 365 days of the study duration, i.e. 52 (=weekly 
visits), 40, 30, 20, 15, 12, 10, 8, 6, 4, 2, and finally 
a single visit. The model results were further used 
for estimating the required sample-size of a study 
using different sampling strategies. We used a re-
lationship allowing the sample-size calculation for 
linear regression for sufficiently large sample-sizes, 
Table 2. Recall error
Day before 
surveillance visit
Probability of report-
ing disease
-1 1.0
-2 1.0
-3 0.74
-4 0.67
-5 0.67
-6 0.58
-7 0.58
Values based on (23)
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which we adapted from that published by Dupont 
and Plummer (26).
        n=(u+v)2/(βSDLP/SDresid)
2                                   [2]
where u is the standard normal deviate value corres- 
ponding to the study power (0.84 for 80% power); v 
is the standard normal deviate value corresponding 
to the assumed significance level (1.96 for p=0.05); 
β is the expected value for the regression slope; SDLP 
is the standard deviation of the dependent variable 
(in this case the longitudinal prevalence of disease); 
and SDresid is the standard deviation of the residuals 
of the regression line. The simulations were done 
in the Stata software (version 9.0). All results were 
averaged over 500 runs which were found to be suf-
ficient to achieve robust estimates. 
RESULTS
Figure 2 shows the association between the number 
of surveillance visits and the size of the estimate 
Fig. 2. Association between number of visits and effect size
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Association (expressed as a slope parameter) between longitudinal prevalence of infection and 
weight gain over one year (y-axis) depending on the number of surveillance visits at regular 
intervals  (x-axis) for the 4 different model scenarios. The true slope parameter of -25 g (dotted 
horizontal line) means that with each percentage increase in longitudinal prevalence, weight
gain over one year is reduced by -25 g. At each visit, a 7-day recall period is applied assuming 
perfect (100%) recall. HL=High incidence of disease and long duration of episode; HS=High 
incidence of disease and short duration of episode; LL=Low incidence of disease and long dura-
tion of episode; LS=Low incidence of disease and short duration of episode.
(the slope parameter – weight gain per year), 
assuming a seven-day recall period at each visit 
and no recall error. Therefore, 52 visits (once every 
week) with seven-day recall provide continuous 
disease records without gaps. The figure shows that 
if the frequency of surveillance decreases from 52 
visits, the estimate is biased from the true value of 
-25 g (per percentage point of the LP) towards zero. 
The effect of bias is particularly pronounced for the 
low-prevalence model scenario 1 (LS).
Figure 3A shows the association between the 
number of visits and the required sample-size to es-
timate the slope parameter, using Equation [2] and 
assuming 80% power and p=0.05. The sample-size 
takes into account the bias in the estimate shown 
in Figure 2. The absolute sample-sizes are much 
higher for the low-prevalence scenario 1 and 2 (LS 
and LL) but the relative increase with the decreasing 
frequency of visit is also more pronounced in these 
scenarios. This is highlighted in Figure 3B which 
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shows the relative increase in the sample-size with 
the sample-size for 52 visits as the reference.   
We then introduced recall error into the models by 
assuming that the probability of an infection being 
reported decreases if the day is more than two days 
before the day of the simulated visit (Table 2). This 
meant that, on average, only 75% of days with in-
fection were recorded as such. For illustration, the 
following calculations were done only for model 
scenario 3 (HS) (the same analysis conducted for 
the other models in principal resulted in similar 
findings). Figure 4A shows the effect recall error 
on the regression coefficient. For a recall period of 
seven days, recall error results in an exaggerated 
estimate of the regression coefficient biased from 
an expected value of 25 g to 32 g per percentage 
point LP (for frequent visits). For comparison pur-
poses, Figure 4A also shows the effect of restricting 
the recall period to one day (where 100% recall was 
assumed) and three days (recall loss of 26% on day 
3 before the visit, Table 2). A one-day recall period 
provides a small underestimation of the true regres-
sion coefficient (23 g instead of the true value of 
25 g per percentage point LP). Using one-day recall 
period at 52 visits is not precise enough to provide 
a fully-unbiased estimate. In contrast, a three-day 
recall period resulted in a small overestimation 
Fig. 3. Association between number of visits and sample-size
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Figure 4B shows the effect of different recall peri-
ods (with recall error assumed as in Figure 4A) on 
the required sample-size of epidemiological stud-
ies. A seven-day recall period requires the smallest 
sample-size but the difference in sample-size to that 
of a three-day recall period is not very large if the 
number of visits exceeds 20.  
Finally, we investigated the effect of using weekly 
period prevalence data rather than point preva-
lence data, assuming the same recall error (Table 
2). Figure 5A shows the coefficients for weekly pe-
riod prevalence data as a function of the number 
of visits (the coefficients for using seven-day point 
prevalence data as in Figure 4A are shown for com-
parison). The estimated regression coefficients for 
weekly period prevalence data are much closer to 
zero than the coefficients for point prevalence data 
because they measure the change in gain in weight 
per additional percentage point LP measured as the 
proportion of weeks with illness. Although period 
prevalence data are much less precise in recording 
the prevalence of infection than point prevalence 
data, the sample-sizes required for a study using pe-
riod prevalence data are only slightly larger than 
for studies using seven-day point prevalence data 
(Fig. 5B).
Infectious diseases and nutritional status Schmidt WP et al.
Volume 29 | Number 4 | August 2011 323
Fig. 4. Effect of recall error on effect size and sample-size 
1 year (only model scenario 3 is shown). The 3 lines indicate 3 different recall periods (1, 3 and 
7 days) applied at each surveillance visit, assuming recall error if the recall period exceeds 2 days. 
Horizontal dotted line indicates true slope parameter (-25 g). (B) Effect of different recall periods 
on the sample-size (calculated as in Figure 3B)
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DISCUSSION
When deciding about the best sampling strategy 
for exploring the association between common in-
fectious diseases and nutritional status, one needs 
to consider the effect of the sampling frequency 
and recall period on the size of the estimate and 
the required sample-size. Our analysis shows that 
random error in the measurement of the disease es-
timates (e.g. due to infrequent visits) can lead to es-
timates biased towards zero while recall error may 
inflate the size of the effect. 
Broadly, our analysis suggests the following rules: 
(a) To obtain estimates within 10% of the true as-
sociation (which for most research questions may 
be acceptable), one has to conduct around 30 visits 
under scenario 1 (low incidence, short duration), 
22 visits under scenario 2 (low incidence, long du-
ration), 18 visits under scenario 3 (high incidence, 
short duration), and 15 visits under scenario 4 (high 
incidence, long duration). 
(b) A three-day recall period as used in some previ-
ous studies (9,21,27) may be the best compromise 
between the risk of inflating the estimate due to 
recall error and the risk of biasing the estimates 
towards null due to imprecision. However, the fi-
nal choice of the recall period may depend on the 
study setting and should follow pilot testing in the 
field. 
(c) There appears to be little advantage of conduct-
ing very many visits (for example in excess of 25), 
as the gains in precision and minimization of bias 
are unlikely to outweigh the logistical effort and 
the potential for jeopardizing the willingness of 
participants to cooperate or influence reporting 
and risk behaviour.
In a previous publication, we investigated the effect 
of varying the sampling frequency on the sample-
size of studies in which the longitudinal prevalence 
of infection is the outcome rather than (as in this 
paper) the exposure (8). We found that, in studies 
with a very low budget for carrying out surveillance 
visits, few visits at long intervals may be an inex-
pensive and efficient alternative to more intensive 
surveillance. If the longitudinal prevalence of in-
fection is the outcome measure, the sampling fre-
quency only affects the precision of the estimates 
such as risk ratio, not its size, regardless of how pre-
cisely disease is measured.
In contrast, if (as in this analysis) the prevalence 
of infection is the exposure variable, the sampling 
frequency not only influences the precision and 
power of a study but also the potential for bias (7), 
the magnitude of which we aimed at quantifying 
in this analysis. The analysis provides guidance on 
the minimum number of visits necessary to ob-
tain valid estimates between recurrent infections 
and nutritional status. A recent article describing a 
randomized water-quality intervention trial found 
strong support for minimizing the number of re-
peat measurements (10). Participants who were fol-
lowed up frequently reported less diarrhoea than 
those sampled at long intervals, possibly due to 
higher recall error and ‘reporting fatigue’. Our mod-
el predicts that, in this situation, recall error can 
lead to bias. Had in this study frequent sampling 
been used for measuring an association between di-
arrhoea and nutritional status, the resulting effect 
estimates probably would have been exaggerated.  
However, regardless of whether the longitudinal 
prevalence of infection is the outcome or the expo-
sure measure, fewer surveillance visits will always 
require a larger sample-size. In a separate paper, 
we estimated for each of the four model scenarios 
(Table 1) factors by which the required sample-size 
needs to be increased to achieve the same power as 
continuous sampling over one year (8). For exam-
ple, if a researcher plans to conduct 20 visits instead 
of 52 over one year (assuming a seven-day recall pe-
riod), the sample-size needs to be increased by 10% 
given model scenario 3 (HS) (8). We found these 
inflation factors to be identical to those applicable 
when calculating the sample-size of studies with 
the prevalence of infection as the exposure variable 
(Fig. 4B). 
We found in this study that using weekly period 
prevalence data rather than point prevalence data 
only requires a slightly larger sample-size but the 
resulting regression coefficients are less intuitive as 
they describe the loss in weight gain per week in 
which infection occurred at any time. Also, as we 
have shown previously, weekly period prevalence 
data are unsuitable as a measure of disease if the 
effect of infections on nutritional status is largely 
due to the differences in the duration of illness but 
not due to the differences in incidence (8). This is 
because individuals who had diarrhoea at some 
point during the last seven days may have suffered 
from one or more episodes of different duration. 
The number of diarrhoea days in the last seven 
days in these individuals may be anything between 
one and seven but when period prevalence data are 
recorded they are all simply coded as ‘diseased at 
any time during the last 7 days’.
We chose gain in weight over one year as outcome 
as a relatively intuitive measure for researchers 
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who are not experts in nutrition. In a sensitivity 
analysis, we tested a range of values for the mean 
and standard deviation of the nutritional status 
measure and the slope parameter of the associa-
tion between infections and nutritional status. We 
found that the choice of these values did not affect 
the model results. This finding may at first appear 
counter-intuitive given the wide range of different 
outcome measures used in nutrition research, such 
as height-for-age, weight-for-height, or weight-
for-age. Some of these measures, such as absolute 
height, commonly increase or remain constant 
whereas relative measures (e.g. z-scores) can in-
crease or decrease. While the choice of different 
outcome measures and of the associated standard 
deviations has a profound impact on the absolute 
sample-size, the relative changes in the sample-size 
due to different sampling frequencies remain con-
stant. It should be noted, however, that our study 
does not include sample-size considerations for re-
peated measurements of nutritional status or for 
interactions, e.g. between exposure (longitudinal 
prevalence of infection) and time. More complex 
analyses with additional assumptions will be need-
ed for such purposes. 
We limited the number of scenarios to just four 
covering a fairly wide range of epidemiological set-
tings and conditions (11). As with any more com-
plex model, the choice of these scenarios was to 
some extent arbitrary but the principal conclusion 
of these analyses was consistent across these con-
trasting scenarios. 
In the models incorporating recall error (Fig. 4 
and 5), our assumptions regarding recall probabili- 
ty of disease on a given day before the visit were 
based on published data (23). These, however, may 
overestimate recall error, since it is plausible that 
the higher prevalence of infection closer to the 
surveillance visit simply indicates that household 
members remember disease during the last seven 
days as having occurred more recently than was 
actually the case. We assumed that recall error oc-
curred independent of the overall disease risk of an 
individual. In reality, it may be that recall error is 
more pronounced in those at a high risk of dis-
ease, which may increase the bias in the association 
between disease and weight gain demonstrated in 
Figure 4 even further. 
Conclusions
Our analysis confirms the risk of bias introduced by 
measurement error in the exposure variable as des- 
cribed in other fields of epidemiologic research (7). 
Our results could provide guidance for choosing an 
appropriate sampling strategy to explore the associ-
ation between recurrent infections and nutritional 
status—or any other outcome variable of interest. 
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